*to main content*
*to side bar*
*to footer with external links*
uni-logo
  • *Your Account*
  • *Log Out*
  • *Institutional Login*
  • *language choice*
    • Language code
    • English
    • Deutsch
uni-logo uni-logo
  • *Catalog* (1)
  • /ulbda/EDS/Advanced?type=AllFields&view= *Article and more*
  • *bs_search_allfields*
  • *bs_search_title*
  • *bs_search_author*
  • *bs_search_topic*
*Advanced* *Search History*
  • Efficacy, safety and different...
  • *Description*
*Cover Image*

*Result*: Efficacy, safety and differential outcomes of immune‐chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: a multicenter real world cohort

*Saved in*:
*Title*:
Efficacy, safety and differential outcomes of immune‐chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: a multicenter real world cohort
*Author/editor-in-chief*:
Mitzlaff, Katharina (Verfasser); Kirstein, Martha (Verfasser) ; Müller, Christian (Verfasser); Venerito, Marino (Verfasser) ; Olkus, Alexander (Verfasser) ; Dill, Michael T. (Verfasser) ; Weinmann, Arndt (Verfasser) ; Kocheise, Lorenz (Verfasser); Busch, Alina (Verfasser); Schulze, Kornelius (Verfasser) ; Allo, Gabriel (Verfasser); Waldschmidt, Dirk-Thomas (Verfasser); Barsch, Maryam (Verfasser); Bengsch, Bertram (Verfasser) ; Quante, Michael (Verfasser) ; González-Carmona, María Á. (Verfasser) ; Himmelsbach, Vera (Verfasser) ; Finkelmeier, Fabian (Verfasser); Klöckner, Roman Trutz (Verfasser) ; Schirmacher, Peter (Verfasser) ; Marquardt, Jens U (Verfasser); Zimpel, Carolin (Verfasser)
*Publication*:
Freiburg : Universität, 2024
*Physical description scale*:
1 Online-Ressource
*Format*:
*eBook*
*Language*:
*eng*
*Notes*:
United european gastroenterology journal. - 12, 9 (2024) , 1230-1242, ISSN: 2050-6414
*DOI*:
10.1002/ueg2.12656

*Additional information*

  • *Holdings*
  • *Description*
  • *Table of Contents*
  • *Staff View*

*Additional functions*

  • *Cite this*
  • *Email this*
  • *Export Record*
    • *Export to* *EndNote*
    • *Export to* *BibTeX*
  • *Add to favorites*
Efficacy, safety and differential outcomes of immune‐chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: a multicenter real world cohort / Mitzlaff, Katharina
HEB524613001

*Footer links*

*Services*

  • *footerHelp*
  • *footerMoreInfo*

*Legal*

  • *footerPrivacy*
  • *footerImprint*

*Contacts*

  • *footerAsk*
  • *footerLocations*
*a product by*
hebis-Logo

*Loading*...